>
Switch to:

Sorrento Therapeutics Total Inventories

: $2.68 Mil (As of Jun. 2021)
View and export this data going back to 2007. Start your Free Trial

Sorrento Therapeutics's total inventories for the quarter that ended in Jun. 2021 was $2.68 Mil. Sorrento Therapeutics's average total inventories from the quarter that ended in Mar. 2021 to the quarter that ended in Jun. 2021 was $2.23 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Sorrento Therapeutics's Net-Net Working Capital per share for the quarter that ended in Jun. 2021 was $-1.55.

Inventory can be measured by days sales of inventory (DSI). Sorrento Therapeutics's days sales of inventory (DSI) for the three months ended in Jun. 2021 was 15.07.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sorrento Therapeutics's Days Inventory for the three months ended in Jun. 2021 was 65.24.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sorrento Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2021 was 1.40.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sorrento Therapeutics's Inventory-to-Revenue for the quarter that ended in Jun. 2021 was 0.17.


Sorrento Therapeutics Total Inventories Historical Data

The historical data trend for Sorrento Therapeutics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sorrento Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Total Inventories
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.90 3.36 1.83

Sorrento Therapeutics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Total Inventories Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.45 2.14 1.83 1.78 2.68

Sorrento Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Sorrento Therapeutics  (NAS:SRNE) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Sorrento Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2021 is

Net-Net Working Capital Per Share (Q: Jun. 2021 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(111.701+0.75 * 22.437+0.5 * 2.684-593.389
-0--0.633)/297.974
=-1.55

2. Inventory can be measured by Days Sales of Inventory (DSI).

Sorrento Therapeutics's Days Sales of Inventory for the three months ended in Jun. 2021 is

Days Sales of Inventory (DSI)
=Total Inventories (Q: Jun. 2021 )/Revenue (Q: Jun. 2021 )*Days in Period
=2.2315/13.511*365 / 4
=15.07

3. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sorrento Therapeutics's Days Inventory for the three months ended in Jun. 2021 is calculated as:

Days Inventory=Total Inventories (Q: Jun. 2021 )/Cost of Goods Sold (Q: Jun. 2021 )*Days in Period
=2.2315/3.121*365 / 4
=65.24

4. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sorrento Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2021 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2021 ) / Total Inventories (Q: Jun. 2021 )
=3.121 / 2.2315
=1.40

5. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sorrento Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2021 is calculated as

Inventory-to-Revenue=Total Inventories (Q: Jun. 2021 ) / Revenue (Q: Jun. 2021 )
=2.2315 / 13.511
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Sorrento Therapeutics Total Inventories Related Terms

Thank you for viewing the detailed overview of Sorrento Therapeutics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Sorrento Therapeutics Business Description

Sorrento Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 325414 SIC : 8731
Traded in Other Exchanges
Address
4955 Directors Place, San Diego, CA, USA, 92121
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.
Executives
Ji Henry director, officer: See Remarks 5370 RUETTE DE MER SAN DIEGO CA 92130
Asghar Najjam officer: Chief Financial Officer C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Janda Kim director 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Lee Edgar director C/O OAKTREE CAPITAL MANAGEMENT, L.P. 333 SOUTH GRAND AVE, 28TH FLOOR LOS ANGELES CA 90071
Wu Yue Alexander director C/O SORRENTO THERAPEUTICS, INC. 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Smith Robin L director C/O PHASE III MEDICAL, INC. 330 SOUTH SERVICE ROAD, SUITE 120 MELVILLE NY 11747
Shah Jaisim director C/O PROTINE DESIGN LAB 37481 MARSTEN DR NEWARK CA 94560
Shao Jiong officer: Chief Financial Officer SUITE 1003-1004, 10/F, ICBC TOWER THREE GARDEN ROAD, CENTRAL HONG KONG F4 000000
Zeldis Jerome B officer: See Remarks 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258
Ally Bridge Group Innovation Capital Partners Iii, L.p. 10 percent owner ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000
Ally Bridge Group Capital Partners Ii, L.p. 10 percent owner ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000
Ferrigno Dean officer: Chief Accounting Officer C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Ng George K officer: See Remarks C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE COURT WEST, SUITE B SAN DIEGO CA 92121
Gu Nana 10 percent owner C/O OFFSHORE INCORPORATIONS LIMITED OFFSHORE INCORPORATIONS CENTRE POBOX 957 ROAD TOWN, TORTOLA D8 VG1110
Asia Pacific Medtech (bvi) Ltd 10 percent owner C/O OFFSHORE INCORPORATIONS LIMITED OFFSHORE INCORPORATIONS CENTRE POBOX 957 ROAD TOWN, TORTOLA D8 VG110

Sorrento Therapeutics Headlines

From GuruFocus

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)